KOAN · Resonate Blends, Inc.
Market Cap
$58,575
Shares
195.25M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–0.02
Avg vol 30d4.4M
Short int46K · 0.0% float · 1.0d
Short vol55%
DataJan 2020–Sep 2026
Filing10-Q · Jun 16
Up next
filed Jun 16, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$2.23M
Trailing 12 months
Net income (TTM)
$1.14M
Trailing 12 months
Revenue growth YoY
+353.2%
Year over year
Operating margin
-72.2%
Trailing 12 months
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 6,666.7%
FCF yield
-1,821.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+19.3%
Year over year · more shares
Price change (1Y)
-93.3%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−33%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
1%
near low
Momentum
relative strength
1-month return
0%
trailing
6-month return
−78%
trailing
YTD return
−87%
this year
Relative strength
−93%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -54.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
20
low risk · 0–100
Fundamentals
Revenue growth
+106%
Y/Y
Gross margin
131%
expanding
EPS growth
0%
Y/Y
Free cash flow
$-1.1M
Quant / Vol
risk profile
Volatility
215%
annualized · 1-yr
Max drawdown
−99%
past year
ATR
25.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−33%
Bearish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -54.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 1%
Range high $0
vs 200-day avg -83%
vs 50-day avg -33%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KOAN
this stock
Resonate Blends, Inc.
|
$58,575 | -87.1% | +105.9% | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.66B | +18.2% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$47.69B | -1.7% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.35B | -2.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KOAN | +0.0% | +0.0% | -77.8% | +0.0% | -87.1% |
| SPY | -0.1% | -0.6% | +14.9% | -0.3% | +12.2% |
| vs SPY | +0.1% | +0.6% | -92.7% | +0.3% | -99.3% |